ArticleCureus2026
Clinical Outcomes of Intradiscal Condoliase Injection for Lumbar Disc Herniation: A Retrospective Analysis of the First 100 Cases.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Intradiscal injection of condoliase is a minimally invasive treatment positioned between conservative management and surgery for lumbar disc herniation (LDH). Objective To evaluate the short- to mid-term clinical course and radiological changes following condoliase treatment in routine clinical practice. Methods This retrospective observational study analyzed 100 consecutive patients with LDH who underwent intradiscal condoliase injection between December 2018 and July 2023. Clinical outcomes were evaluated using the visual analog scale (VAS). Radiological findings were assessed using established magnetic resonance imaging classifications. Clinical outcomes and subsequent treatments were analyzed. Results The median symptom duration was 20 weeks. Mean leg pain VAS significantly improved from 7.4 ± 2.1 at baseline to 3.7 ± 2.4 at one month and 2.4 ± 2.2 at three months (p < 0.05). Symptomatic improvement was observed in 87 patients (87.0%), with a median time to relief of four weeks. Five patients (5.0%) required subsequent surgery. No major complications were observed, including neurological deterioration, infection (discitis), anaphylaxis, hospitalization related to the procedure, or death. Conclusions Intradiscal condoliase injection was associated with a significant early reduction in leg pain in the majority of patients with LDH and may serve as an effective intermediate treatment between conservative management and surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.